Found: 14
Select item for more details and to access through your institution.
Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Rilpivirine efficacy, virology and safety in ARV treatment-naïve patients with viral load≤100,000 HIV-1 RNA c/mL: ECHO and THRIVE 96-week results.
- Published in:
- Journal of the International AIDS Society, 2012, v. 15, p. 1, doi. 10.7448/IAS.15.6.18250
- By:
- Publication type:
- Article
Pooled week 48 safety and efficacy results from the ECHO and THRIVE phase III trials comparing TMC278 vs EFV in treatment-naïve, HIV-1-infected patients.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. O48, doi. 10.1186/1758-2652-13-S4-O48
- By:
- Publication type:
- Article
Efficacy and safety of TMC278 in treatment-naïve, HIV-1-infected patients with HBV/HCV co-infection enrolled in the phase III ECHO and THRIVE trials.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. P210, doi. 10.1186/1758-2652-13-S4-P210
- By:
- Publication type:
- Article
Effect of intrinsic and extrinsic factors on the pharmacokinetics of TMC278 in antiretroviral-naïve, HIV-1-infected patients in ECHO and THRIVE.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. P186, doi. 10.1186/1758-2652-13-S4-P186
- By:
- Publication type:
- Article
Efficacy and safety of TMC278 in treatment-naïve, HIV-1-infected patients with HBV/HCV co-infection enrolled in the phase III ECHO and THRIVE trials.
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Effect of intrinsic and extrinsic factors on the pharmacokinetics of TMC278 in antiretroviral-naïve, HIV-1-infected patients in ECHO and THRIVE.
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Pooled week 48 safety and efficacy results from the ECHO and THRIVE phase III trials comparing TMC278 vs EFV in treatment-naïve, HIV-1-infected patients.
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Week 96 analysis of rilpivirine or efavirenz in HIV-1-infected patients with baseline viral load ≤ 100 000 copies/m L in the pooled ECHO and THRIVE phase 3, randomized, double-blind trials.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Week 96 analysis of rilpivirine or efavirenz in HIV-1-infected patients with baseline viral load ≤ 100 000 copies/m L in the pooled ECHO and THRIVE phase 3, randomized, double-blind trials.
- Published in:
- HIV Medicine, 2014, v. 15, n. 1, p. 57, doi. 10.1111/hiv.12071
- By:
- Publication type:
- Article
Neurological and psychiatric tolerability of rilpivirine ( TMC278) vs. efavirenz in treatment-naïve, HIV-1-infected patients at 48 weeks Neurological and psychiatric tolerability of rilpivirine ( TMC278) vs. efavirenz in treatment-naïve, HIV-1-infected patients at 48 weeks
- Published in:
- HIV Medicine, 2013, v. 14, n. 7, p. 391, doi. 10.1111/hiv.12012
- By:
- Publication type:
- Article
Neurological and psychiatric tolerability of rilpivirine ( TMC278) vs. efavirenz in treatment-naïve, HIV-1-infected patients at 48 weeks Neurological and psychiatric tolerability of rilpivirine ( TMC278) vs. efavirenz in treatment-naïve...
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE
- Published in:
- HIV Medicine, 2012, v. 13, n. 7, p. 406, doi. 10.1111/j.1468-1293.2012.00991.x
- By:
- Publication type:
- Article
Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE Effect of gender and race on the week 48 findings in treatment-naïve,...
- Published in:
- 2012
- By:
- Publication type:
- Journal Article